Cardiff Oncology, Inc. (CRDF) ownership: Top institutional holder: VANGUARD GROUP INC ($10.46M). Insider activity: Net Seller (1 buys, 19 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 3722085.00 | $10.46M | 2025-12-31 |
| BlackRock, Inc. | 3981387.00 | $6.45M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2855966.00 | $4.63M | 2026-03-31 |
| Laurion Capital Management LP | 2646738.00 | $4.29M | 2026-03-31 |
| Pfizer Inc | 2411575.00 | $3.74M | 2026-03-31 |
| ACORN CAPITAL ADVISORS, LLC | 1762084.00 | $2.85M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1599663.00 | $2.59M | 2026-03-31 |
| Point72 Asset Management, L.P. | 508438.00 | $2.21M | 2024-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-04-27 | |
| Sell | null | 2026-04-27 | |
| Sell | null | 2026-04-14 |
Back to CRDF overview · CRDF earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.